Gland Pharma schedules investor meeting with B&K Securities

Gland Pharma Limited has informed stock exchanges about a scheduled group meeting with investors and analysts. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company will hold a group meeting on December 11, 2025.

The meeting, arranged by B&K Securities, will involve discussions between the company and investors/analysts. Gland Pharma Limited emphasizes that the schedule is subject to change based on exigencies from the investor, analyst, or the company itself.

This announcement, dated December 8, 2025, serves as information for records to the BSE Limited and the National Stock Exchange of India Limited. The communication was signed by Sampath Kumar Pallerlamudi, company secretary & compliance officer of Gland Pharma Limited.